12/3
04:05 pm
lung
Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
High
Report
Pulmonx Announces Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
11/16
01:10 am
lung
Medium
Report
11/13
09:01 am
lung
Pulmonx (NASDAQ:LUNG) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $14.00 price target on the stock.
High
Report
Pulmonx (NASDAQ:LUNG) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $14.00 price target on the stock.
11/13
06:04 am
lung
How Recent Shifts Are Rewriting the Story for Pulmonx [Yahoo! Finance]
High
Report
How Recent Shifts Are Rewriting the Story for Pulmonx [Yahoo! Finance]
11/12
07:25 pm
lung
Pulmonx outlines $89M–$90M 2025 guidance with renewed focus on execution and cost discipline [Seeking Alpha]
High
Report
Pulmonx outlines $89M–$90M 2025 guidance with renewed focus on execution and cost discipline [Seeking Alpha]
11/12
07:22 pm
lung
Pulmonx Corporation (LUNG) Q3 2025 Earnings Call Transcript [Seeking Alpha]
High
Report
Pulmonx Corporation (LUNG) Q3 2025 Earnings Call Transcript [Seeking Alpha]
11/12
04:53 pm
lung
Pulmonx Reports Third Quarter 2025 Financial Results [Yahoo! Finance]
High
Report
Pulmonx Reports Third Quarter 2025 Financial Results [Yahoo! Finance]
11/12
04:05 pm
lung
Pulmonx Reports Third Quarter 2025 Financial Results
High
Report
Pulmonx Reports Third Quarter 2025 Financial Results
11/1
07:18 am
lung
Is Pulmonx Corporation (LUNG) One of the Best Stocks Under $3 to Invest In? [Yahoo! Finance]
Medium
Report
Is Pulmonx Corporation (LUNG) One of the Best Stocks Under $3 to Invest In? [Yahoo! Finance]
10/28
11:09 am
lung
Pulmonx (NASDAQ:LUNG) was given a new $4.00 price target on by analysts at Lake Street Capital.
High
Report
Pulmonx (NASDAQ:LUNG) was given a new $4.00 price target on by analysts at Lake Street Capital.
10/28
08:09 am
lung
Pulmonx (NASDAQ:LUNG) had its price target lowered by analysts at D. Boral Capital from $16.00 to $14.00. They now have a "buy" rating on the stock.
Medium
Report
Pulmonx (NASDAQ:LUNG) had its price target lowered by analysts at D. Boral Capital from $16.00 to $14.00. They now have a "buy" rating on the stock.
10/27
04:05 pm
lung
Pulmonx Announces Management Transition and Preliminary Third Quarter 2025 Revenue; Reschedules Third Quarter 2025 Earnings Call to November 12, 2025
High
Report
Pulmonx Announces Management Transition and Preliminary Third Quarter 2025 Revenue; Reschedules Third Quarter 2025 Earnings Call to November 12, 2025
10/15
04:05 pm
lung
Pulmonx to Report Third Quarter 2025 Financial Results on October 29, 2025
Low
Report
Pulmonx to Report Third Quarter 2025 Financial Results on October 29, 2025
10/4
12:06 am
lung
Medium
Report
9/8
08:05 am
lung
Pulmonx (NASDAQ:LUNG) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $16.00 price target on the stock.
Medium
Report
Pulmonx (NASDAQ:LUNG) had its "buy" rating reaffirmed by analysts at D. Boral Capital. They now have a $16.00 price target on the stock.